Metabolic syndrome throughout the menopausal transition: Influence of age and menopausal status

Climacteric

Volumn 9, Issue 1, 2006, Pages 40-48

  Mesch, V R ^a   Boero, L E ^a   Siseles, N O ^b   Royer, M ^b   Prada, M ^b   Sayegh, F ^b   Schreier, L ^a   Benencia, H J ^a   Berg, G A ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

Author keywords

Insulin resistance; Menopausal transition; Metabolic syndrome; Triglycerides HDL cholesterol ratio

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; AGING; AMENORRHEA; ARTICLE; CARDIOVASCULAR DISEASE; CLIMACTERIUM; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LINEAR REGRESSION ANALYSIS; MENOPAUSE; MENSTRUAL CYCLE; MENSTRUATION; METABOLIC SYNDROME X; NORMAL HUMAN; OBESITY; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; CHOLESTEROL, HDL; FEMALE; HUMANS; HYPERTENSION; LINEAR MODELS; MENOPAUSE; METABOLIC SYNDROME X; MIDDLE AGED; TRIGLYCERIDES; WAIST-HIP RATIO;

EID: 31544458199     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.1080/13697130500487331     Document Type: Article

References (34)

1. Kannel W, Hjortland M, McNamara P, Gordon T. Menopause and risk of cardiovascular disease: The Framingham study. Ann Intern Med 1976;85:447-52
2. Parini P, Bo A, Rudling M. Importance of estrogen receptors in hepatic LDL receptor regulation. Arterioscler Thromb Vasc Biol 1997;17:1800-5
3. Berg G, Siseles N, Gonzalez A, et al. Higher values of hepatic lipase in postmenopause: relationship with atherogenic intermediate density and low density lipoproteins. Menopause 2001;8:51-7
4. Li Z, McNamara JR, Fruchart JC, et al. Effects of gender and menopausal status on plasma lipoprotein subspecies and particle sizes. J Lipid Res 1996;37:1886-96
5. De Aloysio D, Gambacciani M, Meschia M, et al. The Icarus Study Group. The effect of menopause on blood lipid and lipoprotein levels. Atherosclerosis 1999;147:147-53
6. Berg G, Mesch V, Boero L, et al. Lipid and lipoprotein profile in menopausal transition. Effects of hormones, age and fat distribution. Horm Metab Res 2004;36:215-20
7. Ferrara CM, Lynch N, Nicklas B, Ryan S, Berman D. Differences in adipose tissue metabolism between postmenopausal and perimenopausal women. J Clin Endocrinol Metab 2002;87:4166-70
8. Park YW, Zhu S, Palaniappan L, et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-36
9. Wilson PW, Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999;159:1104-9
10. Despres JP. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 1993;9:452-9
11. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005;16:1415-28
12. Matthews K, Wing R, Kuller L, Meilahn E, Plantinga P. Influence of the menopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Arch Intern Med 1994;154:2349-55
13. McAuley KA, Williams SM, Mann JI, et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001;24:460-4
14. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9
15. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10
16. Ascaso JF, Pardo S, Real JT, et al. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 2003;26:3320-5
17. Santoro N, Chervenak JL. The menopause transition. Endocrinol Metab Clin N Am 2004;33:627-36
18. 2+ precipitation for quantitation of high-density lipoprotein cholesterol. Clin Chem 1982;28:137-8
19. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP). JAMA 2001;285:2486-97
20. Tankó L, Bagger Y, Qin G, Alexandersen P, Larsen P, Christiansen C. Enlarged waist combined with elevated triglycerides is a strong predictor of accelerated atherogenesis and related cardiovascular mortality in postmenopausal women. Circulation 2005;111:1883-90
21. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am 2004;33:351-75
22. Hajamor S, Després JP, Couillard C, et al. Relationship between sex hormone-binding globulin levels and features of the metabolic syndrome. Metabolism 2003;52:724-30
23. Meigs J, Wilson P, Nathan D, et al. Prevalence and characteristics of the metabolic syndrome in the San Antonio Heart and Framingham Offspring Studies. Diabetes 2003;52:2160-7
24. The IDF consensus worldwide definition of the metabolic syndrome. (online) 2005:http://www.idf.org
25. Solymoss BC, Bourassa MG, Campeau L, et al. Effect of increasing metabolic syndrome score on atherosclerotic risk profile and coronary artery disease angiographic severity. Am J Cardiol 2004;93:159-64
26. Munoz J, Derstine A, Gower B. Fat distribution and insulin sensitivity in postmenopausal women: influence of hormone replacement. Obes Res 2002;10:424-31
27. Carr M. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 2003;88:2404-11
28. Pascot A, Despres JP, Lemieux I, et al. Deterioration of the metabolic risk profile in women. Respective contributions of impaired glucose tolerance and visceral fat accumulation. Diabetes Care 2001;24:902-8
29. Ascaso JF, Romero P, Real JT, et al. Insulin resistance quantification by fasting insulin plasma values and HOMA index in a non-diabetic population Med Clin (Barc) 2001;117:530-3
30. Carr M, Brunzell J. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. J Clin Endocrinol Metab 2004;89:2601-7
31. Haarbo J, Marslew U, Gotfredsen A, Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991;40:1323-6
32. Chang C, Wu C, Yao W, et al. Relationships of age, menopause and central obesity on cardiovascular disease risk factors in Chinese women. Int J Obes 2000;24:1699-704
33. McLaughlin T, Abbasi F, Cheal K, et al. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 2003;139:802-9
34. LaMonte M, Ainsworth B, DuBose K, et al. The hypertriglyceridemic waist phenotype among women. Atherosclerosis 2003;171:123-30